Central serous chorioretinopathy and the sclera: what we have learned so far

被引:4
|
作者
Koizumi, Hideki [1 ]
Imanaga, Naoya [1 ]
Terao, Nobuhiro [1 ]
机构
[1] Univ Ryukyus, Grad Sch Med, Dept Ophthalmol, 207 Uehara, Nishihara, Okinawa 9030215, Japan
关键词
Central serous chorioretinopathy; Pachychoroid; Sclera; Uveal effusion syndrome; Vortex vein; INDOCYANINE GREEN ANGIOGRAPHY; PHOTODYNAMIC THERAPY; VORTEX VEIN; THICKNESS; LOCULATION; FEATURES; EFFUSION; FLUID;
D O I
10.1007/s10384-024-01101-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Central serous chorioretinopathy (CSC) is a common disorder characterized by serous retinal detachment. Several studies using indocyanine green angiography (ICGA) have revealed that choroidal filling delay, choroidal vascular dilation, and choroidal vascular hyperpermeability are the characteristic findings of CSC. These ICGA findings confirm that choroidal circulatory disturbances are the primary factors in the pathogenesis of CSC. With advancements in optical coherence tomography (OCT), choroidal thickness has been found to be significantly greater in eyes with CSC than in normal eyes. Dilated large choroidal vessels reportedly account for the thickened choroid in eyes with CSC. Although many possible mechanisms and risk factors have been suggested, the pathophysiologic features of choroidal circulatory disturbances and choroidal thickening in eyes with CSC have not yet been fully elucidated. Recently, using anterior segment OCT, we proposed that the sclera may induce choroidal circulatory disturbances since CSC eyes have significantly thicker sclera than do normal eyes. This review summarizes updated information on the close relationship between CSC pathogenesis and the sclera.
引用
收藏
页码:419 / 428
页数:10
相关论文
共 50 条
  • [41] Hypopharyngeal dedifferentiated liposarcoma: What we have learned so far
    Touli, Ermioni
    Manganaris, Argyrios
    Katsiki, Evangelia
    Karasmanis, Ilias
    ORAL ONCOLOGY, 2021, 123
  • [42] COVID-19: What We Have Learned So Far
    Clifford, Theresa
    JOURNAL OF PERIANESTHESIA NURSING, 2020, 35 (04) : 445 - 446
  • [43] So, what have we learned?
    Hyde, Brendan
    Ota, Cathy
    Yust, Karen-Marie
    INTERNATIONAL JOURNAL OF CHILDRENS SPIRITUALITY, 2011, 16 (03) : 195 - 196
  • [44] So what have we learned?
    Elston, H. J.
    JOURNAL OF CHEMICAL HEALTH & SAFETY, 2010, 17 (01): : 3 - 3
  • [45] Circadian Clocks in Fish-What Have We Learned so far?
    Steindal, Inga A. Froland
    Whitmore, David
    BIOLOGY-BASEL, 2019, 8 (01):
  • [46] Nutrition-sensitive agriculture: What have we learned so far?
    Ruel, Marie T.
    Quisumbing, Agnes R.
    Balagamwala, Mysbah
    GLOBAL FOOD SECURITY-AGRICULTURE POLICY ECONOMICS AND ENVIRONMENT, 2018, 17 : 128 - 153
  • [47] Classifying Information Systems Risks: What Have We Learned So Far?
    Wiesche, Manuel
    Keskinov, Hristo
    Schermann, Michael
    Krcmar, Helmut
    PROCEEDINGS OF THE 46TH ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, 2013, : 5013 - 5022
  • [48] Sex Hormones and Colorectal Cancer: What Have We Learned So Far?
    Lin, Jennifer H.
    Giovannucci, Edward
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (23): : 1746 - 1747
  • [49] LENR Research Documentation Initiative: What Have We Learned So Far?
    Grimshaw, Thomas W.
    JOURNAL OF CONDENSED MATTER NUCLEAR SCIENCE, 2024, 38 : 235 - 244
  • [50] A DECADE OF SEQUENTIAL CODING IN MI: WHAT HAVE WE LEARNED SO FAR?
    Houck, J. M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 65A - 65A